New EU legal measures, which entered into force this month, will see three harmful new psychoactive substances (NPS) brought under control across the EU. The substances — all new synthetic cathinones — are: 2-methylmethcathinone (2-MMC), 4-bromomethcathinone (4-BMC) and N-ethylnorpentedrone (NEP). These are now classified as controlled ‘drugs’ under EU law.
The decision to control the substances was introduced by the European Commission last year through a Delegated Directive, amending the existing legal framework designed to bring a stronger and faster response to NPS in Europe (1). The…
Read more
This month, the EUDA assumed the year-long presidency of the EU Justice and Home Affairs Agencies’ Network (JHAAN), which is composed of nine agencies: CEPOL, EIGE, EUAA, EUDA, EU-LISA, EUROJUST, EUROPOL, FRA and FRONTEX. The presidency theme, ‘One Safety — building preparedness and resilient communities’, promotes a cross-sector integrated approach to building a safer, fairer and…
Read more
Effective drug monitoring in Europe depends on strong cooperation with Member States. In a new publication out today, we outline the key features of the Reitox Alliance, a new partnership framework between the EUDA and the national focal points (NFPs) of the Reitox network. The publication (Reitox Alliance operating framework) sets out the scope of the Alliance, the partners involved, its core tasks and governance arrangements.
Adopted by our Management Board in December 2025, the Reitox Alliance replaces the previous Reitox operating framework (in place since 2003) and aligns the…
Read more
